Bipolar Disorders: Mixed States, Rapid-Cycling, and Atypical Forms

349 The treatment of bipolar mixed statesKraepelin, E. (1921). Manic Depressive Insanity and Paranoia. Edinburgh: E. & S. Livingstone.Kramlinger, K. G. and Post, R. M. (1996). Ultra-rapid and ultradian cycling in bipolar affectivedisorder. Br. J. Psychiatry, 168, 314–23.Krishnan, R. R., Maltbie, A. A., and Davidson, J. R. T. (1983). Abnormal cortisol supression inbipolar patients with simultaneous manic and depressive symptoms. Am. J. Psychiatry,140, 203–5.Kukopulos, A. and Reginaldi, D. (1973). Does Lithium prevent depression by suppressingmanias? Int. Pharmopsychiatry, 8, 152–8.Licht, R. W. (2002). Limits of the applicability and generalizability of drug trials in mania.Bipolar Disord., 4 (suppl. 1), 66–8.Licht, R. W., Gouiaev, G., Vestergard, P., et al. (1997). Generalisability of results from randomiseddrug trials. Br. J. Psychiatry, 170, 264–7.Littlejohn, R., Leslie, F., and Cookson, J. (1994). Depot antipsychotics in the prophylaxis ofbipolar affective disorder. Br. J. Psychiatry, 165, 827–9.Lowe, M. R. and Batchelor, D. H. (1990). Lithium and neuroleptics in the management ofmanic-depressive psychosis. Hum. Psychopharmacol., 5, 267–74.Mander, A. J. and Loudon, J. B. (1998). Rapid recurrence of mania following abrupt discontinuationof lithium. Lancet, ii, 15–17.Marneros, A. and Angst, J. (2000). Bipolar disorders: roots and evolution. In Bipolar Disorders:100 Years After Manic-Depressive Insanity, ed. A. Marneros and J. Angst, pp. 1–36. Dordrecht:Kluwer.McElroy, S. L., Freeman, M. P., and Akiskal, H. S. (2000). The mixed bipolar disorders.In: Bipolar Disorders; 100 Years after Manic-Depressive Insanity, ed. A. Marneros and J. Angst,pp. 63–88. Dordrecht: Kluwer.McGuffin, P., Reveley, A. and Holland, A. (1982). Identical triplets: non-identical psychosis.Br. J. Psychiatry, 140, 1–6.Moore, P. B., Shepherd, D., Ecclestone, D. J., et al. (2001). Cerebral white matter lesions inbipolar affective disorder: relationship to outcome. Br. J. Psychiatry, 178, 172–6.Muller-Oerlinghausen, B., Ahren, B., Grof, E., et al. (1992). The effects of long-term lithiumtreatment on the mortality of patients with manic-depressive and schizo-affective illness. ActaPsychiatri. Scand., 86, 218–22.Muller-Oerlinghausen, B., Retzow, A., Henn, F. A., et al. (2000). Valproate as an adjunct toneuroleptic medication for the treatment of acute episodes of mania: a prospective, randomizeddouble-blind, placebo-controlled, multicentre study. European Valproate Mania StudyGroup. J. Clin. Psychopharmacol., 20, 195–203.Murphy, D. L. and Beigel, A. (1974). Depression, elation, and lithium carbonate responses inmanic patient subgroups. Arch. Gen. Psychiatry, 31, 543–8.Nilsson, F. M., Kessing, L. V., Sorensren, T. M., Andersen, P. K., and Bolwig, T. G. (2002). Therisk of developing depression and mania in patients with dementia. Poster: Third EuropeanStanley Foundation Conference, Freiburg. Bipolar Disord., 4 (suppl. 1), 132.Okasha, A. (2002). Difficulties in evaluating the economics of bipolar disorder in developingcountries. In Bipolar Disorder, ed. M. Maj, H. S. Akiskal, J. J. Lopez-Ibor, and N. Sartorius,pp. 496–8. WPA series: Evidence and Experience in Psychiatry. Chichester, UK: John Wiley.